Amsterdam Rheumatology and Immunology Center, Reade, 1056 AB Amsterdam, The Netherlands.
Amsterdam UMC, Amsterdam Medical Center, 1105 AZ Amsterdam, The Netherlands.
Nutrients. 2021 Sep 15;13(9):3208. doi: 10.3390/nu13093208.
Chronic inflammation plays a central role in the pathophysiology of various non-communicable diseases. Dietary interventions can reduce inflammation, in part due to their effect on the gut microbiome. This systematic review aims to determine the effect of dietary interventions, specifically fiber intake, on chronic inflammatory diseases and the microbiome. It aims to form hypotheses on the potential mediating effects of the microbiome on disease outcomes after dietary changes. Included were clinical trials which performed a dietary intervention with a whole diet change or fiber supplement (>5 g/day) and investigated the gut microbiome in patients diagnosed with chronic inflammatory diseases such as cardiovascular disease (CVD), type 2 diabetes (T2DM), and autoimmune diseases (e.g., rheumatoid arthritis (RA), inflammatory bowel disease (IBD)). The 30 articles which met the inclusion criteria had an overall moderate to high risk of bias and were too heterogeneous to perform a meta-analysis. Dietary interventions were stratified based on fiber intake: low fiber, high fiber, and supplemental fiber. Overall, but most pronounced in patients with T2DM, high-fiber plant-based dietary interventions were consistently more effective at reducing disease-specific outcomes and pathogenic bacteria, as well as increasing microbiome alpha diversity and short-chain fatty acid (SCFA)-producing bacteria, compared to other diets and fiber supplements.
慢性炎症在各种非传染性疾病的病理生理学中起着核心作用。饮食干预可以减少炎症,部分原因是它们对肠道微生物组的影响。本系统评价旨在确定饮食干预,特别是纤维摄入,对慢性炎症性疾病和微生物组的影响。它旨在形成关于微生物组在饮食改变后对疾病结果的潜在介导作用的假设。纳入的研究是对患有慢性炎症性疾病(如心血管疾病 (CVD)、2 型糖尿病 (T2DM) 和自身免疫性疾病(如类风湿关节炎 (RA)、炎症性肠病 (IBD))的患者进行全饮食改变或纤维补充剂 (>5 g/天) 的饮食干预的临床试验,并调查了肠道微生物组。符合纳入标准的 30 篇文章总体上存在中度至高度偏倚风险,且异质性太大,无法进行荟萃分析。饮食干预根据纤维摄入量进行分层:低纤维、高纤维和补充纤维。总的来说,但在 T2DM 患者中更为明显,与其他饮食和纤维补充剂相比,富含纤维的植物性饮食干预更有效地降低特定疾病的结局和致病菌,同时增加微生物组 α 多样性和产生短链脂肪酸 (SCFA) 的细菌。